TTK, CDC25A, and ESPL1 as Prognostic Biomarkers for Endometrial Cancer

Figure 8

Analysis between TTK, CDC25A, and ESPL1 expression and clinical features of EC. (a) Correlation analysis between TTK, CDC25A, and ESPL1 expression with EC stage; early stage means stage I and stage II; late stage means stage III and stage IV. (b) Correlation analysis between TTK, CDC25A, and ESPL1 expression with tumour grade. (c) Correlation between TTK, CDC25A, and ESPL1 expression and survival of EC.

(a)

(b)

(c)